Amphastar Pharmaceuticals Inc (AMPH) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Amphastar Pharmaceuticals Inc   (NASDAQ: AMPH)
 

Amphastar Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Amphastar Pharmaceuticals Inc inventory turnover ratio, the Amphastar Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.14 in the second quarter 2026, yet the ratio remained below the average, as AMPH's market remain challenging.Average inventory processing period, for the Amphastar Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 171 days, compare to 175 days, in the Mar 31 2026 quarter.

Within Healthcare sector 187 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1532, from total ranking in the first quarter 2026 at 1705.

AMPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Amphastar Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMPH Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -6.17 % -8.24 % 15.06 % 42.68 % 56.63 %
Y / Y Cost of Sales Growth 2.85 % 18.26 % -2.44 % 4.39 % 0.8 %
Inventory Turnover Ratio (TTM) 2.14 2.09 1.97 2.04 2.19
AMPH's Total Ranking # 1532 # 1705 # 1587 # 1536 # 1448
Average inventory processing period 170 174 186 179 167
Seq. Inventory Growth 5.71 % -3.79 % -4.86 % -3.02 % 3.37 %
Seq. Cost of Sales Growth -10.33 % 3.5 % 4.55 % 5.99 % 3.1 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 188
Overall Market # 1532

Inventory Turnover Ratio Statistics
High Average Low
2.9 2.28 1.29
(Dec 31 2018)   (Sep 30 2016)



AMPH Company Profile >> Back to AMPH Efficiency Comparisons >> Compare AMPH Inventory Turnover Ratio to its Competitors

Financial Statements
Amphastar Pharmaceuticals Inc 's Inventories $ 180 Millions Visit AMPH's Balance sheet
Amphastar Pharmaceuticals Inc 's Cost of Revenues TTM $ 382 Millions Visit AMPH's Income Statement
What are AMPH's Sales? Visit AMPH's Sales by Segment

Other Inventory Turnover Ratios
Amphastar Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AMPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AMPH's Competitors
Inventory Turnover Ratio for AMPH's Suppliers
Inventory Turnover Ratio for AMPH's Customers

You may also want to know
AMPH's Sales Growth Rates AMPH's Pe Price to earnings ratio AMPH's Receivables Turnover Ratio AMPH's Stock Quote
AMPH's Net Income Growth Rates AMPH's Ps Price to Sales ratio AMPH's Sales per Employee AMPH's Asset Turnover Ratio
AMPH's Net Margin AMPH's Pb Price to Book ratio AMPH's Financial Strength Ratios AMPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions

Date modified: 2026-09-08T01:08:10+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.